ProKidney (PROK) AGM 2026 summary

Opening remarks and agenda

• Meeting conducted in a hybrid format to maximize stockholder participation worldwide.

• Agenda and rules of conduct were provided on the meeting website.

• Formal business included introduction of board members and management team.

Board and executive committee updates

• Board members and committee chairs were introduced, including Audit, Talent and Compensation, and R&D Committees.

• Management team and independent auditor from Ernst & Young were present.

Shareholder proposals

• Two proposals were considered: election of three director nominees and ratification of Ernst & Young as independent auditor for 2026.

• No other nominations for directors were received.